June 1-5, 2018




Full Day Sessions from 08:30 to 16:30

WS01: Introduction to Information Retrieval for Health Technology Assessment (HTA)
This workshop, organized by the HTAi Information Retrieval Interest Group (IRG), will be presented by a variety of speakers from a number of countries and continents. Participants (information specialists and others) will learn about searching for HTA and other evidence syntheses, discuss issues relevant to their own search practices and hear how other HTA organizations organize their services.

WS02: Introduction to Ethics in Health Technology Assessment
This workshop,organised under auspices of the INAHTA/HTAi Interest Group on Ethical Issues in Health Technology Assessment (HTA), offers a lively introduction to learn and apply methods that can be used to explore potential ethical implications of health technology. No specific knowledge or expertise in the area of ethics is required.The objective of this workshop is to learn about, and apply, methods that can be used to explore potential ethical implications of health technology.

WS03: Overviews of Systematic Reviews: An Emerging Methodology in Health Technology Assessment
Overviews of systematic reviews represent an emerging evidence synthesis method that is increasingly being used within health technology assessment as a means to reduce research waste by leveraging previous evidence synthesis efforts. In this workshop, participants will be introduced to the key steps involved in conducting overviews of systematic reviews, including challenges that emerge in their conduct and potential solutions. Participants can expect to leave this workshop equipped with the knowledge and skills to recognize situations in which overviews represent an appropriate evidence synthesis methodology, with a focus on overviews of reviews of intervention effectiveness. Participants will be able to describe the key steps and existing guidance on conducting overviews, appreciate challenges to conducting overviews, identify potential solutions and appreciate areas of future work for overviews.


Morning Sessions from 08:30 to 12:00

WS05: HTA101: Introduction to Health Technology Assessment

This popular workshop has been updated and offered at all HTAi Annual Meetings. It provides an understanding of important HTA concepts, methods and current HTA issues and trends that will enable attendees to fully engage in the scientific program of the Annual Meeting. It is appropriate for both those who are new to HTA and those who want a “refresher” course. HTA101 will provide (1) a fundamental understanding of HTA for those who are new to the field, (2) a refresher or content update for those with some HTA experience (including new methodological developments), and (3) greater ability to engage in, and gain, from the scientific program and other aspects of the Annual Meeting.

WS06: A Primer in Regulatory Interactions and Conditional Coverage
The HTAi Regulatory Interactions and Conditional Coverage (RICC) Interest Group (IG) suggests this workshop in order to satisfy professionals’ and students’ needs in understanding the current status of interactions between regulatory and HTA bodies, as well as conditional coverage schemes and value-based healthcare. It also seeks to increase interest in RICC activities. The objectives of this workshop are to communicate the activities of the RICC IG; to compare European and North American landscape regulatory and HTA interactions; to discuss methods of conditional coverage and value-based evaluations as subtleties of drugs versus medical devices evaluation; to share return of experience from previous implementations; and to discuss required evidence and how to generate it.

WS07: Complex Interventions for HTA – Real World Experience: Let’s Make Them Simple Together
This is an introductory-level course about complex interventions and their increasing role in HTA. The main objectives of this workshop are to provide basic knowledge about complex interventions, their design, implementation and evaluation; to discuss the increasing role of complex interventions and their context in comparative effectiveness and HTA; to discuss challenges related to statistical analysis and economic evaluation of complex interventions; and to learn about (1) real world applications and challenges of feasibility, piloting and implementation of complex interventions, and (2) the use of different study designs (e.g. pragmatic trials) and administrative databases in design, implementation and evaluation of complex interventions.


Afternoon Sessions from 13:00 to 16:30

WS08: Editors’ Secrets for Authors: How to Get Your Manuscript Accepted
This interactive workshop, arranged by editors of the International Journal of Technology Assessment in Health Care (IJTAHC), will guide authors in structuring and presenting their manuscripts well. Small-group work at the start will elicit participants’ questions on how to submit or revise papers; these guide the workshop content. A detailed presentation of the IJTAHC submission system is included. After the workshop, participants will have an overview of how manuscripts are submitted, evaluated and revised. They will also know about typical reasons for rejection and will be more knowledgeable about the requirements for revision. 

WS09: Use of Evidence to Decision Frameworks in HTA: Increasing Stakeholder Involvement and Transparency
There is an increasing stakeholders’ demand for both broader participation of patients in particular and a greater transparency in the entire HTA process. Use of explicit and transparent systems that consider all important criteria for making a decision, such as Evidence to Decision (EtD) frameworks supported by GRADEpro software, can help in this process. The outcomes of this workshop will be to provide an insight into how the HTA decision-making process can be carried out and presented in a more structured manner that is transparent for all stakeholders involved, and to incorporate the added value of participation of stakeholders, particularly patients, into the HTA decision-making process. This workshop will provide participants with practical knowledge of GRADE and EtD frameworks for a transparent HTA development process, especially for outcome selection and prioritization, involving different stakeholders, particularly patients, prior to performing the evidence synthesis and using EtD frameworks to reach an informed and transparent decision.

WS10: Applied Techniques in Costing Studies: Collection and Use of Real World Data in Microcosting Studies
This workshop will present the steps for conducting cost-studies for HTA, either for specific procedures or clinical conditions, and provide interactive activities based on real cases of different backgrounds. Participants will learn applied methods of micro-costing, particularly using Absorption Costing and Time Driven Activity Based Costing techniques, to assess real world costs for HTA.

WS11: Early HTA: A Case Study of Pre-Market Evaluation
Early evaluation of health technologies is collaboratively implemented by policymakers, industry and academia to select and expedite the development of emerging technologies that may address the needs of patients and health systems. This workshop will provide theoretical and practical knowledge on early HTA using a case study of a Canadian-grown technology and will familiarize participants with early HTA methods. Through a case study application, participants will learn the intricacies of making adoption decisions regarding a pre-market disruptive technology.




Full Day sessions from 08:30 to 16:30

WS12: Advanced Information Retrieval on the Edge: Real World Evidence, Living SRs and Reporting Standards
The Information Retrieval Group (IRG) advanced skills workshop provides an opportunity for information specialists and others interested in information retrieval to come together to network and discuss important issues in HTA information management and systematic review work. This workshop will leave participants with knowledge to help them both in their daily work as information specialists and in their overall approach to information retrieval in HTA. The topics presented are of cutting edge focus. As real world evidence becomes increasingly recognized as a valuable source of information and more prevalent in systematic reviews and health technology assessment, information specialists will need to know how to retrieve published studies that incorporate this data. Likewise, the active surveillance of evidence is increasingly important for updating evidence syntheses. Information specialists need to understand the unique information retrieval needs of these types of reviews, especially living systematic reviews. The documentation and reporting of literature searches, while not new, nevertheless needs to become more standardized. This workshop will help participants decide on the minimum standards needed for search reporting and documentation, with a focus on transparency and reproducibility. Taken together, the topics presented in this workshop will provide participants with a better understanding of topics at the cutting edge of HTA information retrieval.

WS13: Building a Shared Resource of Patient Experience and Preferences to Improve HTA
This workshop presents the issue of the burden of patient input in HTA and seeks to identify solutions by developing participants knowledge of common gaps, issues and overlaps in patient input sought for HTAs, awareness of existing shared resources of patient experience and how they function, ability to identify potential collaborators and approaches to building shared resources such as repositories. This workshop explores opportunities to reduce the burden of patient input in HTA for patients and patient groups, and increase its value through creating shared resources. Participants will gain awareness of existing resources for capturing and sharing patient experience and preferences, and approaches to tackling the burden of patient input; an understanding of the requirements for capturing and sharing patient experience for HTA; and experience of collaborating to scope potential solutions to the issue.

WS14: HTA 102, Hospital-Based HTA (HB-HTA) in the HTA Ecosystem: A Role in Improving Public Health Care
HTA is an approach to manage technological innovation and disinvestment decisions. An effective HTA system should be an integrated environment where interaction occurs at all levels (international, national, regional and local). Hospital Based HTA (HB-HTA) (local level) is expanding internationally. The objective of this workshop is to introduce managers and health care professionals to HB-HTA and HTA Ecosystem principles. This workshop aims to (1) explore the main features of health care organizational management and the rationale for HB-HTA, (2) describe HTA and HB-HTA application models in an integrated HTA ecosystem and (3) provide an overview of HB-HTA methods, tools and case studies of successful local HTA impact.

WS15: Evidence Implementation in Performance Based Financing in Primary Healthcare at District Level
Evidence implementation is a challenge at district level in low middle-income countries due to the paucity of relevant research evidence and lack of access to evidence. This workshop will contribute to HTA capacity building through an approach to build capacity in assessing research evidence from primary research, systematic reviews and clinical practice guidelines in LMIC. At the end, it will develop a comprehensive tool for evidence implementation that can be used in LMIC and made available on the GIN database. Participants will gain knowledge and skills on evidence assessment and implementing research into practice using an innovative approach. Participants will also take away tools for evidence assessment. In addition, the workshop moderators will be available after the conference to assist participants who are conducting evidence implementation projects.

Morning sessions from 08:30 to 12:00

WS16: The Current State of Affairs in Health Technology Reassessment
Policy decisions concerning health technologies have shifted from primarily evidence-informed adoption of new technologies, to evidence-informed management of technologies throughout their lifecycle. This workshop will introduce the concepts and process of HTR to participants and provide an overview of the current state of affairs internationally. It identifies five learning objectives: (1) to discuss the concept of and need for Health Technology Reassessment (HTR), (2) to gain awareness of current and past international HTR initiatives, (3) to identify how different jurisdictions are moving into action to reduce low-value care, (4) to identify common and unique implementation challenges within different contexts, and (5) to facilitate the next steps in the International Health Technology Management Agenda.

WS17: Expert Elicitation For Health Technology Assessment: The What, Why and How?
This workshop provides a practical introduction to the process of expert elicitation, why and where it can be used in HTA, and best practices from published methodologies. The workshop is aimed at individuals in industry and research who are interested in learning about the concepts and methods for incorporating expert opinion into HTA via expert elicitation. It will provide attendees with a clear understanding of the methods of expert elicitation, the application of expert elicitation to HTA and the practical steps to conduct expert elicitation

WS18: How to Make a Guideline: Just Add Health Technology Assessment
As information brokers, HTA researchers can bridge the knowledge to action gap by serving as an “engine room” for developing best evidence summaries to inform recommendation formulation in guideline development. An international team of HTA researchers share their experiences of melding HTA and guideline adaptation methodologies to expedite guideline development and strengthen the evidence to action. This workshop will provide a forum for learning, discussing and sharing expertise on using HTA in guideline development. This workshop will be of particular interest for researchers involved in CPG development and HTA organizations planning to initiate such work in their jurisdictions.

WS19: Adaptation of Health Technology Assessment Reports: An Effective Way to Use Limited Resources?
Many reports are available on the same topic developed at different times depending upon the time of entry of technology into markets; it is time and resource-saving process to make best use of these available literature, thus avoiding duplication of work. Facilitated by staff of HTA agencies, this workshop will engage with participants to explore ways to adapt. Participants will learn from shared experiences of adaptation of HTA reports conducted in different health systems and methods, which can be applied to various aspects of adaptation processes.

WS20: Uncertainty and the Value of Precision Medicine
Precision Medicine (PM) promises to revolutionize health care, and global regulatory authorities are lowering the evidentiary standards in response. This amplifies substantial uncertainty in the evidence base for these high-cost approaches to care. This workshop will discuss how payers can manage uncertainty to support the realization of PM’s promise. The objective of this workshop is to share the insights developed at Precision Medicine Policy Network meeting, with a view to triggering a wider debate on how developers, analysts and payers should identify, quantify and value the uncertainty in the evidence base for PM technologies.


Afternoon sessions from 13:00 to 16:30

WS21: Access With Evidence Generation Designing Managed Access Programs
Managed Access Programs offer the opportunity to provide early and targeted access to important and promising new therapies while addressing key sources of uncertainty. However, these agreements also present several challenges. This workshop will describe success stories from a variety of jurisdictions, discuss best practices from multiple perspectives, and provide a hands-on opportunity to craft MAPs for specific therapies. The objective of this workshop is to provide HTA professionals with experience in the design of MAPs, with instruction from experienced individuals of a variety of backgrounds and disciplines. The intended outcome of this workshop is to provide greater familiarity with these techniques and a richer understanding of the opportunities, needs and priorities of the affected stakeholder groups.

WS22: Using the AGREE II Tool to Direct the Development and Appraisal of Clinical Practice Guidelines
This workshop will introduce participants to the AGREE II, a tool for the development and appraisal of clinical practice guidelines. Participants will apply the tool to a clinical practice guideline and reach consensus in a small group. Large group discussions will address challenges with applying the AGREE II and how the tool might be useful for the HTA community. The interactive structure of this workshop will allow participants to gain hands-on experience with applying the AGREE II to a clinical practice guideline and identifying any challenges related to using the tool. This workshop will serve to increase awareness of the AGREE II in the HTA community. By the end of this workshop session, participants will understand the key components of high quality clinical practice guidelines; know how to apply the AGREE II to a clinical practice guideline to appraise its methodological quality; be able to distinguish between clinical practice guidelines of higher and lower quality; gain understanding about the relationship between clinical practice guidelines and HTAs; and receive suggestions about how the AGREE II could be used or adapted by HTA developers and users.

WS23: From Evidence to Action – Rapid Review Methods for HTA
Rapid reviews are increasingly important within HTA. Although there are many rapid review methods available, there is little guidance available on how to choose the most appropriate methods. This workshop aims to enable participants to have a clear understanding of possible approaches to rapid review, as well as improve their skills in selecting the most appropriate methods. By the end of this workshop, participants will have a clear understanding of possible approaches and improved their skills for selecting appropriate rapid review methods. Participants will be able to describe important considerations, including limitations, to take into account when discussing rapid review approaches with commissioners or policy-makers; evaluate scoping search results and identify appropriate rapid review methods based on the results; select possible approaches to data extraction and synthesis based on characteristics of included studies; and report methods used in a transparent manner together with limitations.

WS24: New Ways of Exploring the Health Technology Horizon
The proposed workshop will describe and introduce people into the data driven area of early awareness, appropriate care and disinvestment. New technologies on identifying knowledge, preparing summaries for HTA and/or priritization processes will be shown by examples, as well as how to collaborate and use collaborative knowledge. The aim of this workshop is to raise the ability of participants to know about existing scientific frameworks on horizon scanning, quality aspects and tools to describe existing knowledge, the use of  shared tools to improve the finding and the use of identified knowledge. Participants should get an in-depth awareness of interactive tools and collaborative structures of HTAi and EuroScan.

WS25: A Hands-On Workshop from INAHTA on the ‘How To’ of HTA Impact Assessment
Many HTA agencies evaluate the impact (or influence) of their HTA reports. Participants in this educational workshop will learn about how to conceptualize and measure HTA impact. Facilitated by staff at HTA agencies from INAHTA, this session will engage participants in a hands-on activity to apply the INAHTA Impact Framework to new case studies. It will offer value to those interested to learn about HTA programs and the decision makers they inform. Participants will enjoy a mix of educational talks, story sharing and case study analysis to learn about different approaches to assessing HTA influence; facilitators and barriers to conducting assessments of HTA impact; ways that HTAs can influence different types and ‘levels’ of decisions; and limitations and challenges in HTA impact assessment. Participants will leave the session with a deepened understanding of the conceptual and practical aspects of measuring HTA impact, and gain a greater sense of confidence in creating or adapting an impact assessment process to their local health care setting.